Freedman Lori bought ORGO
February 18, 2026 · Form 4 insider transaction
Freedman Lori bought 42,780 shares of Organogenesis Holdings Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
42,780
Price
$0.00
Total value
N/A
InsiderFreedman Lori
Role—
SecurityClass A Common Stock
Transaction codeA: Grant or award
Transaction dateFebruary 18, 2026
Filing dateFebruary 20, 2026
Shares owned after1,037,622
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares issued pursuant to the vesting and settlement of a performance share award granted in 2025 based on the achievement of certain performance milestones.